Welcome to DukeHealth.org.
Skip over navigation
  • Home
  • Patient and Visitor Info
  • Physicians
  • Services
  • Clinical Trials
  • Event Calendar
  • Locations
  • Health Library
  • About Duke Medicine

Quick Links

  • Appointments
  • HealthView Patient Login
  • Quality and Safety
Home > Physicians > Hall, Russell P.
Jumbo Large Regular Text:
Print
Physicians

Russell P. Hall, MD

Related Content

Locations

  • Duke Dermatology

Services

  • Autoimmune and Blistering Diseases

Health Library

  • Best Doctors 2011-2012 Award Winners

Share

Russell P. Hall, MD

Chair, Department of Dermatology

Departments / Divisions
  • Dermatology
  • Immunology

Address
DUMC 3135
Durham, NC 27710

Appointment Telephone
919-684-3432

Office Telephone
919-684-3110

Fax Telephone
919-684-3002

Training
  • MD, University of Missouri-Columbia School of Medicine, 1975

Residency
  • Internal Medicine, Saint Louis University (Missouri), 1975-1976
  • Internal Medicine, University of Missouri, 1976-1977
  • Dermatology, University of Missouri, 1977-1978
  • Dermatology, Johns Hopkins University (Maryland), 1981-1982

Fellowship
  • Dermatology Branch, National Institutes of Health (Maryland), 1978-1981

Clinical Interests
Immunologically mediated skin diseases, blistering skin diseases (dermatitis herpetiformis, bullous pemphigoid, pemphigus, cicatricial pemphigoid), immunofluorescence testing

Research Interests

Our laboratory is investigating the pathogenesis of autoimmune blistering skin diseases. Areas of special expertise include immune mediated skin diseases, especially immune mediated primary blistering disorders. These include pathogenesis, diagnosis, and management.
Specifically our laboratory is investigating the role of the mucosal immune response in the pathogenesis of dermatitis herpetiformis (DH) and the role the associated gluten sensitive enteropathy (GSE) plays in the development of this disease. Studies are currently focused on understanding the systemic manifestations of the mucosal immune response to dietary ingestion of wheat proteins in patients with DH. Studies are directed at determining the pattern of cytokine activation and inflammatory cell activation in the gut, skin and circulation. These studies are focused on understanding the manner in which gastrointestinal inflammation leads to the development of skin lesions in patients with DH and will provide new insight into the pathogenesis of the numerous skin diseases associated with inflammatory gastrointestinal disease.
In addition, our laboratory is investigating the pathogenesis of the organ specific auto immune blistering diseases bullous pemphigoid, and pemphigus vulgaris. These studies are directed at understanding auto-antibody epitopes and their relationship to disease activity and the role of B cells in the development and maintaince of auto-antibodies. Clinical trials are ongoing in both pemphigus and bullous pemphigoid that are coupled with mechanistic studies.

Industry Relationships and Collaborations (What's this?)

This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.

  • Centocor, Inc. (Johnson & Johnson)
  • Genentech, Inc (Roche Holding)
  • Society for Investigative Dermatology
  • Stiefel (GSK company)
  • Vernalis Pharmaceuticals, Inc.

Representative Publications
Hall, RP; Takeuchi, F; Benbenisty, KM; Streilein, RD. Cutaneous endothelial cell activation in normal skin of patients with dermatitis herpetiformis associated with increased serum levels of IL-8, sE-Selectin, and TNF-alpha. Journal of Investigative Dermatology. 2006;126:1331-1337. (2006) Abstract

Suarez, EC; Boyle, SH; Lewis, JG; Hall, RP; Young, KH. Increases in stimulated secretion of proinflammatory cytokines by blood monocytes following arousal of negative affect: the role of insulin resistance as moderator. Brain, Behavior, and Immunity. 2006;20:331-338. (2006) Abstract

Kong, HH; Prose, NS; Ware, RE; Hall, RP. Successful treatment of refractory childhood pemphgus vulgaris with anti-CD20 monoclonal antibody (rituximab). Pediatric Dermatology. 2005;22:461-464. (2005) Abstract

Whited, JD; Hall, RP; Foy, ME; Marbrey, LE; Grambow, SC; Dudley, TK; Datta, SK; Simel, DL; Oddone, EZ. Patient and clinician satisfaction with a store-and-forward teledermatology consult system. Telemedicine and e-Health. 2004;10:422-431. (2004) Abstract

Takeuchi, F; Sterilein, RD; Hall, RP. Increased E-selectin, IL-8 and IL-10 gene expression in human skin after minimal trauma. Experimental Dermatology. 2003;12:777-783. (2003) Abstract

Smith, AD; Streilein, RD; Hall, RP. Neutrophil CD11b, L-selectin and Fc IgA receptors in patients with dermatitis herpetiformis. British Journal of Dermatology. 2002;147:1109-1117. (2002) Abstract

Szabolcs, P; Reese, M; Yancey, KB; Hall, RP; Kurtzberg, J. Combination treatment of bullous pemphigoid with anti-CD20 and anti-CD25 antibodies in a patient with chronic graft-versus-host disease. Bone Marrow Transplantation. 2002;30:327-329. (2002) Abstract

Hall, RP; Owen, S; Smith, A; Keough, M; Bagheri, B; Church, P; Streilein, R. TCR Vbeta expression in the small bowel of patients with dermatitis herpetiformis and gluten sensitive enteropathy. Limited expression in dermatitis herpetiformis and treated asymptomatic gluten sensitive enteropathy. Experimental Dermatology. 2000;9:275-282. (2000) Abstract

Hall, RP; Smith, AD; Streilein, RD. Increased production of IL-4 by gut T-cell lines from patients with dermatitis herpetiformis compared to patients with isolated gluten-sensitive enteropathy. Digestive Diseases and Sciences. 2000;45:2036-2043. (2000) Abstract

Roh, JY; Yee, C; Lazarova, Z; Hall, RP; Yancey, KB. The 120-kDa soluble ectodomain of type XVII collagen is recognized by autoantibodies in patients with pemphigoid and linear IgA dermatosis. British Journal of Dermatology. 2000;143:104-111. (2000) Abstract

Rico, MJ; Benning, C; Weingart, ES; Streilein, RD; Hall, RP. Characterization of skin cytokines in bullous pemphigoid and pemphigus vulgaris. British Journal of Dermatology. 1999;140:1079-1086. (1999) Abstract

Smith, AD; Bagheri, B; Streilein, RD; Hall, RP. Expression of interleukin-4 and interferon-gamma in the small bowel of patients with dermatitis herpetiformis and isolated gluten-sensitive enteropathy. Digestive Diseases and Sciences. 1999;44:2124-2132. (1999) Abstract

Ishii, K; Amagai, M; Hall, RP; Hashimoto, T; Takayanagi, A; Gamou, S; Shimizu, N; Nishikawa, T. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins. Journal of Immunology. 1997;159:2010-2017. (1997) Abstract

Rico, MJ; Hashimototo, T; Watanabe, K; Hall, RP; Clark, RB; Nishikawa, T. Comparative epitope mapping of sera from United States (US) and Japanese patients with bullous pemphigoid (BP) to fusion proteins encoded by BPAG1. Journal of Dermatological Science. 1996;12:238-245. (1996) Abstract

Contact Us | Careers | Privacy Policy | Make a Gift | Site Map | RSS Feeds | En EspaƱol | Mobile Site | Help
Duke Medicine | Duke School of Medicine | Duke Children's | Duke University
Toll-Free: 888-ASK-DUKE (888-275-3853)
Copyright © 2004-2013 Duke University Health System

About This Page

Updated: Dec. 12, 2006
Published: Dec. 12, 2006
URL: http://www.dukehealth.org/physicians/russell_p_hall